A B S T R A C T In acute experimental diabetes in animals, alpha-cell unresponsiveness to hyperglycemia can be promptly corrected by insulin, but in human diabetes, even massive doses of insulin have little effect. To determine if this inability of insulin to correct the alphacell abnormality in man is merely the consequence of the long duration of the diabetic state (rather than of a difference in mechanism), the effect of insulin was studied in alloxan diabetes of long duration. Alloxan-diabetic dogs were maintained for 7-18 mo and treated daily with insulin. When glucose was infused without insulin, glucagon did not decline but rose paradoxically.
INTRODUCTION
In normal human subjects (1) and dogs (2, 3) , glucagon secretion is intimately related to blood glucose concentration and declines promptly when the glucose level rises. In both inherited and experimental diabetes this relationship is disturbed; glucagon secretion is at all times inappropriately high relative to the blood glucose level and is not suppressed by hyperglycemia (4) (5) (6) . The two forms of diabetes differ strikingly with respect to the ability of insulin to restore alpha-cell function to normal. In experimental diabetes, the abnormality is promptly corrected by the administration of insulin in physiologic quantities, suggesting that it is the consequence of insulin lack (6) , whereas in human diabetes alpha-cell unresponsiveness to hyperglycemia is only minimally improved by insulin, even in pharmacologic quantities (7) . Moreover, the alpha-cell defect in human diabetes appears to be unrelated either to the type or the severity of the diabetes, to the degree of control, or to the level of plasma insulin and is observed in relatively mild diabetes with essentially normal plasma levels of immunoreactive insulin, as well as in severe insulinrequiring diabetics (4, 5) .
On the basis of the inability of insulin to normalize the unresponsiveness of the alpha cell to hyperglycemia in human genetic diabetes, and because alpha and beta cells develop from a common anlage, it has been suggested that the alpha-cell defect in genetic diabetes is not secondary to insulin lack but might represent a primary alpha-cell defect inherited with the beta-cell defect (8) .
As pointed out, a major point in favor of this suggestion is the striking difference between alloxan-diabetic dogs and human diabetics with respect to the ability of insulin to correct the alpha-cell unresponsiveness to hyperglycemia. However, since the human diabetics studied had been diabetic for at least 6 .P<o.oi .)P<0,051
was measured by the radioimmunoassay of Yalow and
Berson (9) as modified by Herbert, Law, Gottlieb, and Bleicher (10) . Glucagon was measured as described previously (11) . 30K antiserum, which is highly specific for pancreatic glucagon, was used for all of the glucagon assays.
RESULTS Hyperglycemia responsiveness of the alpha cell in long-standing alloxan diabetes. To determine the hyperglycemia responsiveness of the alpha cell in the absence of additional insulin in long-standing acquired diabetes, glucose was infused at a rate of 8.8 mg/kg/ min in six dogs with alloxan diabetes of 7-12 mo duration. The mean glucagon, insulin, and glucose levels are shown in Fig. 1 . In contrast to the 55 pg/ml decline observed in three normal dogs (Fig. 1) , in the alloxandiabetic dogs, plasma glucagon remained at or above the fasting level of 122 pg/ml throughout the 3 h experiment, and rose paradoxically to a peak of 180 pg/ml at 75 min despite a mean glucose level of 358 mg/100 ml at that time. Plasma insulin averaged approximately 6 AU/ ml throughout the experiment. The increase in glu- min and, at its peak, represented a mean increase of approximately 60 pg/ml above the mean base-line value. It is clear that in dogs with long-standing alloxan diabetes, a rising plasma glucose level not only failed to suppress glucagon secretion but seemed to provoke a paradoxical increase.
The effect of large amounts of insulin on alpha-cell responsiveness to hyperglycemia. To determine if marked hyperinsulinemia, comparable to the high levels that had failed to restore normal alpha-cell responsiveness to hyperglycemia in human diabetics, would do so in dogs with long-standing alloxan diabetes, glucagonfree insulin was infused at a rate of 9 mU/kg/min, together with glucose at a rate of 13.4 mg/kg/min, in a group of seven dogs with diabetes of from 7 to 12 mo duration. The results are shown in Fig. 2 . 120 min after the start of the glucose-insulin infusion, at which point insulin had reached a mean level of 637 uU/ml (SEM± 128), mean glucagon had declined significantly (P < 0.01) below the base-line level of 171 pg/ml (SEM+34) to a nadir of 49 pg/ml (SEM±9). This sustained suppression of glucagon occurred in every animal and was statistically significant (P < 0.02) as early as 20 min, the first time point examined.
In Fig. 3 , these results are compared with the previously reported findings in human diabetics (7) . In the humans, despite the sustained hyperinsulinemia, glu- cagon declined only 11 pg/ml or 11% of the base-line level in 30 min, whereas in the dogs, glucagon declined 105 pg/ml or 61% in 40 min.
It is clear from these results that long duration of acquired diabetes did not abolish the ability of insulin to correct alpha-cell responsiveness.
The effect of smiall amounts of inisulin ont alpha-cell unresponsiveness to hyperglycemia. Althouighi the foregoing experiments reveal that in long-standing alloxan diabetes alpha-cell suppression by hyperglycemia can be fully restored by massive hyperinsulinemia, they do not indicate if small amounts of insulin also fully restore it, as in alloxan diabetes of short duration. To determine if long duration of acquired diabetes causes a loss in the response to small quantities of insulin, four dogs with alloxan diabetes of 18 mo duration were given an infusion of glucagon-free insulin at a rate of only 1.4 mU/ kg/min. The results are shown in Fig. 4 . Within 10 min, at which point the mean insulin had risen only 43 ,uU/ ml, glucagon had already declined in every dog. As insulin rose to a peak level of 71 /U/ml, glucagon continued to fall to a mean nadir of 44 pg/ml at 90 min. In Fig. 5 these results are compared with identical studies, previously reported in dogs with alloxan diabetes of 3 wk duration or less (6) . Clearly, long duration of alloxan diabetes did not impair the ability of small amounts of insulin to restore alpha-cell responsiveness to hyperglycemia.
DISCUSSION
The findings provide evidence that the effectiveness of insulin in restoring alpha-cell responsiveness to hyperglycemia is neither lost nor impaired in alloxan-diabetic dogs controlled on insulin for periods of up to 18 mo.
They suggest that the relative ineffectiveness of insulin previously observed in human diabetes (7) may not be secondary to the long-standing beta-cell insufficiency, but rather a primary disorder. The fact that both alpha and beta cells originate from pancreatic ductular epithelium provides an ontogenic basis for the notion that if the diabetic beta cell is genetically defective, the diabetic alpha cell may also be defective. However, it is possible that factors in the human diabetics studied other than a genetic alpha abnormality accounted for the results.
Nevertheless, this information fits well with previous reports that alpha-cell unresponsiveness to hyperglycemia is present in well-controlled diabetics (4) 
